Open AccessSuccessful management of phenytoin and phenobarbitone induced gingival enlargement: A multimodal approach
Author(s) -
V Priyadharshini,
Vinita V Belure,
MG Triveni,
Ashish Kumar,
Dhoom Singh Mehta
Publication year - 2014
Publication title -
contemporary clinical dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.289
H-Index - 21
eISSN - 0976-237X
pISSN - 0976-2361
DOI - 10.4103/0976-237x.132365
Subject(s) - gingival enlargement , phenytoin , medicine , intensive care medicine , epilepsy , dentistry , psychiatry
Medication-related gingival enlargement is a common reactionary phenomenon that occurs with the use of several types of therapeutic agents, including antiepileptic drugs (AEDs). This disorder has been documented since 1939, shortly after the introduction of phenytoin. In the present case, a concise review of literature concerning the etiopathogenesis and management of AEDs (phenobarbitone and phenytoin) induced gingival enlargement has been described. It is vital that not only the periodontist, but also dental surgeons and medical practitioners should become aware of the potential etiologic agents, characteristic features, and the differential diagnosis of drug induced gingival enlargement in order to be able to prevent, diagnose and successfully manage the condition.